Download presentation
Presentation is loading. Please wait.
1
Substance-Related and Addictive Disorders
Chapter 14 Substance-Related and Addictive Disorders
2
Substance use disorders Substance induced disorders
Substance abuse, substance dependence (addiction) Substance induced disorders Intoxication, withdrawal Dementia, amnesia, psychosis, mood and anxiety disorders
3
Substance Use Disorder
Substance dependence (Addiction) Physical dependence Need for increasing amounts to produce the desired effects (tolerance) Syndrome of withdrawal upon cessation Psychological dependence Overwhelming desire to repeat the use of a particular drug to produce pleasure or avoid discomfort
4
Substance Use Disorder (cont’d)
Substance Addiction (cont’d) Use of the substance interferes with ability to fulfill role obligations Attempts to cut down or control use fail Intense craving for the substance Excessive amount of time spent trying to obtain the substance or recover from its use
5
Substance Use Disorder (cont’d)
Substance Addiction (cont’d) Use of the substance causes the person difficulty with interpersonal relationships or to become socially isolated Engages in hazardous activities when impaired by the substance Tolerance develops and the amount required to achieve the desired effect increases Substance-specific symptoms occur upon discontinuation of use
6
Substance-Induced Disorders
Substance Intoxication Development of a reversible syndrome of symptoms following excessive use of a substance Direct effect on the central nervous system Disruption in physical and psychological functioning Judgment is disturbed and social and occupational functioning is impaired
7
Substance-Induced Disorders (cont’d)
Substance Withdrawal Development of symptoms that occurs upon abrupt reduction or discontinuation of a substance that has been used regularly over a prolonged period of time Symptoms are specific to the substance that has been used Disruption in physical and psychological functioning, with disturbances in thinking, feeling, and behavior
8
Classes of Psychoactive Substances
Alcohol Caffeine Cannabis Hallucinogens Inhalants Opioids Sedatives/hypnotics Stimulants Tobacco
9
Predisposing Factors Biological factors
Genetics: apparent hereditary factor, particularly with alcoholism Biochemical: alcohol may produce morphine-like substances in the brain that are responsible for alcohol addiction
10
Predisposing Factors (cont’d)
Psychological factors Developmental influences Punitive superego Fixation in the oral stage of psychosexual development S. Freud
11
Predisposing Factors (cont’d)
Psychological factors (cont’d) Personality factors: certain personality traits are thought to increase a tendency toward addictive behavior, including Low self-esteem Frequent depression Passivity Inability to relax or defer gratification Inability to communicate effectively
12
Predisposing Factors (cont’d)
Sociocultural factors Social learning: children and adolescents more likely to use substances with parents who provide model for substance use Use of substances may also be promoted within peer group
13
Predisposing Factors (cont’d)
Sociocultural factors (cont’d) Conditioning: pleasurable effects from substance use act as a positive reinforcement for continued use of substance Cultural and ethnic influences: some cultures are more prone to substance abuse than others
14
Alcohol Use Disorder Patterns of use
Phase I. Prealcoholic phase: characterized by use of alcohol to relieve everyday stress and tensions of life. Phase II. Early alcoholic phase: begins with blackouts—brief periods of amnesia that occur during or immediately following a period of drinking; alcohol is now required by the person. Feeling guilty but defensive about drinking
15
Alcohol use disorders Patterns of use (cont’d)
Phase III. The crucial phase: person has lost control; physiological dependence is clearly evident. S/S: binge drinking, anger, agression, loss of job, marriage or family Phase IV. The chronic phase: characterized by emotional and physical disintegration. The person is usually intoxicated more often than sober. Severe withdrawal symptoms, depression, suicidal ideation
16
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body Reversible depression of the CNS At low doses, alcohol produces: Relaxation Lack of concentration Drowsiness Slurred speech Sleep
17
Dynamics of Substance-Related Disorders (cont’d)
Alcohol intoxication: occurs at blood alcohol levels between 100 and 200 mg/dl Alcohol withdrawal: occurs within 4 to 12 hours of cessation of or reduction in heavy and prolonged alcohol use
18
Effects of alcohol on the body (chronic use or intoxication)
Peripheral neuropathy, characterized by Peripheral nerve damage Pain Burning Tingling Prickly sensations of the extremities
19
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Alcoholic myopathy: thought to result from same B vitamin deficiency that contributes to peripheral neuropathy Acute: sudden onset of muscle pain, swelling, and weakness; reddish tinge to the urine; rapid rise in muscle enzymes in the blood Chronic: gradual wasting and weakness in skeletal muscles
20
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Wernicke’s encephalopathy: most serious form of thiamine deficiency in alcoholic patients S/S: paralysis of ocular muscle, diplopia, ataxia, stupor Korsakoff’s psychosis: syndrome of confusion, loss of recent memory, and confabulation in alcoholic patients
21
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Alcoholic cardiomyopathy: effect of alcohol on the heart is an accumulation of lipids in the myocardial cells, resulting in enlargement and a weakened condition Arrhythmias, Congestive heart failure
22
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Esophagitis: inflammation and pain in the esophagus occurs because of the toxic effects of alcohol on the esophageal mucosa and also because of frequent vomiting associated with alcohol use
23
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Gastritis: effects of alcohol on the stomach include inflammation of the stomach lining characterized by epigastric distress, nausea, vomiting, and distention
24
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Pancreatitis Acute: usually occurs 1 or 2 days after a binge of excessive alcohol consumption. Symptoms include constant, severe epigastric pain; nausea and vomiting; and abdominal distention
25
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Pancreatitis (cont’d) Chronic: leads to pancreatic insufficiency resulting in steatorrhea, malnutrition, weight loss, and diabetes mellitus
26
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Alcoholic hepatitis Caused by long-term heavy alcohol use Symptoms: enlarged, tender liver; nausea and vomiting; lethargy; anorexia; elevated white cell count; fever; and jaundice. Also ascites and weight loss in severe cases.
27
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Cirrhosis of the liver Cirrhosis is the end-stage of alcoholic liver disease and is believed to be caused by chronic heavy alcohol use. There is widespread destruction of liver cells, which are replaced by fibrous (scar) tissue.
28
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Cirrhosis of the liver (cont’d) Portal hypertension: elevation of blood pressure through the portal circulation results from defective blood flow through cirrhotic liver
29
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Cirrhosis of the liver (cont’d) Ascites: a condition in which an excessive amount of serous fluid accumulates in the abdominal cavity; occurs in response to portal hypertension
30
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Cirrhosis of the liver (cont’d) Esophageal varices: veins in the esophagus become distended because of excessive pressure from defective blood flow through the cirrhotic liver
31
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Cirrhosis of the liver (cont’d) Hepatic encephalopathy: occurs in response to the inability of the diseased liver to convert ammonia to urea for excretion. The continued rise in serum ammonia, if allowed to progress, leads to coma and eventual death.
32
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Leukopenia: impaired production, function, and movement of white blood cells Thrombocytopenia: platelet production and survival are impaired as a result of the toxic effects of alcohol
33
Dynamics of Substance-Related Disorders (cont’d)
Effects of alcohol on the body (cont’d) Sexual dysfunction In the short term, enhanced libido and failure of erection are common Long-term effects include gynecomastia, sterility, impotence, and decreased libido
34
Dynamics of Substance-Related Disorders (cont’d)
2. A client is brought to the ED. The client is aggressive, has slurred speech, and impaired motor coordination. Blood alcohol level is 347 mg/dl. Among the physician’s orders is thiamine. Which is the rationale for this intervention? a) To prevent nutritional deficits b) To prevent pancreatitis c) To prevent alcoholic hepatitis d) To prevent Wernicke's encephalopathy
35
Dynamics of Substance-Related Disorders (cont’d)
Correct answer: D Wernicke’s encephalopathy is the most serious form of thiamine deficiency in clients diagnosed with alcoholism. If thiamine replacement therapy is not undertaken quickly, death will ensue.
36
Dynamics of Substance-Related Disorders (cont’d)
Alcohol use during pregnancy can result in fetal alcohol spectrum disorders (FASDs) Fetal alcohol syndrome (FAS): problems with learning, memory, attention span, communication, vision, and hearing Alcohol-related neurodevelopmental disorder Alcohol-related birth defects
37
Dynamics of Substance-Related Disorders (cont’d)
No amount of alcohol during pregnancy is considered safe Alcohol can damage a fetus at any stage of pregnancy
38
Dynamics of Substance-Related Disorders (cont’d)
Characteristics of FAS Abnormal facial features Small head size Shorter-than-average height Low body weight Poor coordination Hyperactive behavior Difficulty paying attention Poor memory Difficulty in school Learning difficulties Speech and language delays Intellectual disability Poor reasoning skills Sleep and sucking problems as a baby Vision or hearing problems Problems with the heart, kidneys, or bones
39
Treatment Modalities for Substance-Related Disorders
Alcoholics Anonymous A major self-help organization for the treatment of alcoholism Based on the concept of Peer support Acceptance Understanding from others who have experienced the same problem
40
Treatment Modalities for Substance-Related Disorders (cont’d)
Alcoholics Anonymous (cont’d) The 12 steps that embody the philosophy of AA provide specific guidelines on how to attain and maintain sobriety. Total abstinence is promoted as the only cure; the person can never safely return to social drinking.
41
Treatment Modalities for Substance-Related Disorders (cont’d)
Various support groups patterned after AA but for individuals with problems with other substances Counseling Group therapy
42
Treatment Modalities for Substance-Related Disorders (cont’d)
Pharmacotherapy for alcoholism Disulfiram (Antabuse) Other medications Naltrexone (ReVia) Nalmefene (Revex) SSRIs Acamprosate (Campral)
43
Treatment Modalities for Substance-Related Disorders (cont’d)
Psychopharmacology for substance intoxication and substance withdrawal Alcohol Benzodiazepines Anticonvulsants Multivitamin therapy Thiamine
44
Dynamics of Substance-Related Disorders (cont’d)
Sedative/Hypnotic Use Disorder A profile of the substance Barbiturates Non-barbiturate hypnotics Antianxiety agents (diazepam, alprazolam) Club drugs
45
Sedative/Hypnotic Use Disorder
Patterns of use Effects on the body Effects on sleep and dreaming Respiratory depression Cardiovascular effects (hypotension, decreased cardiac output) Renal function
46
Sedative/Hypnotic Use Disorder (cont’d)
Effects on the body (cont’d) Hepatic effects (jaundice, increase enzymes function) Body temperature (hypothermia) Sexual functioning
47
Sedative/Hypnotic-Induced Disorder
Intoxication With these CNS depressants, effects can range from disinhibition and aggressiveness to coma and death Impaired judgement, unsteady gait, slurred speech Withdrawal Onset of symptoms depends on the half-life of the drug from which the person is withdrawing. Severe withdrawal from CNS depressants can be life threatening. Sweating, tachycardia, insomnia, N/V, anxiety, seizures
48
Dynamics of Substance-Related Disorders
Stimulant Use Disorder A profile of the substance Amphetamines Synthetic stimulants Non-amphetamine stimulants Cocaine Caffeine Nicotine
49
Stimulant Use Disorder
Patterns of use Effects on the body CNS effects Cardiovascular effects Pulmonary effects Gastrointestinal and renal effects Sexual functioning
50
Stimulant-Induced Disorders
Intoxication Amphetamine and cocaine intoxication produce euphoria, impaired judgment, confusion, changes in vital signs (even coma or death, depending on amount consumed). Caffeine intoxication usually occurs following consumption in excess of 250 mg. Restlessness and insomnia are the most common symptoms.
51
Stimulant-Induced Disorders (cont’d)
Withdrawal Amphetamine and cocaine withdrawal may result in dysphoria, fatigue, sleep disturbances, and increased appetite. Withdrawal from caffeine may include headache, fatigue, drowsiness, irritability, muscle pain and stiffness, and nausea and vomiting. Withdrawal from nicotine may include dysphoria, anxiety, difficulty concentrating, irritability, restlessness, and increased appetite.
52
Inhalant Use Disorder A profile of the substance
Aliphatic and aromatic hydrocarbons found in substances such as fuels, solvents, adhesives, aerosol propellants, and paint thinners They act as CNS depressants
53
Inhalant Use Disorder (cont’d)
Patterns of use/abuse Effects on the body CNS effects (neuropathy) Respiratory effects (dyspnea, pulmonary hypertension, ARD) Gastrointestinal effects (unusual breath odor, mouth rash) Renal system effects (renal failure)
54
Inhalant-Induced Disorder
Intoxication Develops during or shortly after use of or exposure to volatile inhalants Symptoms include Dizziness, ataxia, muscle weakness Euphoria, excitation, disinhibition, slurred speech Nystagmus, blurred or double vision Psychomotor retardation, hypoactive reflexes Stupor or coma
55
Dynamics of Substance-Related Disorders
Opioid Use Disorder A profile of the substance Opioids of natural origin (morphine, opium) Opioid derivatives (heroin) Synthetic opiate-like drugs (oxycodone)
56
Opioid Use Disorder Patterns of use/abuse Effects on the body
CNS effects (euphoria, drowsiness, pupillary constriction, respiratory depression) Gastrointestinal effects (constipation) Cardiovascular effects (hypotension) Sexual functioning (decreased libido)
57
Opioid-Induced Disorders
Intoxication Symptoms are consistent with the half-life of most opioid drugs and usually last for several hours. Symptoms include initial euphoria followed by apathy, dysphoria, psychomotor agitation or retardation, and impaired judgment. Severe opioid intoxication can lead to respiratory depression, coma, and death.
58
Opioid-Induced Disorders (cont’d)
Withdrawal From short-acting drugs (e.g., heroin) Symptoms occur within 6 to 8 hours, peak within 1 to 3 days, and gradually subside in 5 to 10 days From long-acting drugs (e.g., methadone) Symptoms occur within 1 to 3 days, peak between days 4 and 6, and subside in 14 to 21 days From ultra-short-acting meperidine Symptoms begin quickly, peak in 8 to12 hours, and subside in 4 to 5 days
59
Opioid-Induced Disorders (cont’d)
Symptoms of opioid withdrawal Dysphoria, muscle aches, nausea/vomiting, lacrimation or rhinorrhea, pupillary dilation, sweating, abdominal cramping, diarrhea, yawning, fever, and insomnia
60
Hallucinogen Use Disorder
A profile of the substance Naturally occurring hallucinogens Synthetic compounds Patterns of use Use is usually episodic
61
Hallucinogen-Induced Disorder
Intoxication Occurs during or shortly after using the drug Symptoms include perceptual alteration, depersonalization, derealization, tachycardia, palpitations
62
Hallucinogen-Induced Disorder (cont’d)
Symptoms of PCP intoxication include belligerence and assaultiveness and may proceed to seizures or coma
63
Hallucinogens: Effects on the Body
Physiological Nausea/vomiting Chills Pupil dilation Increased BP, pulse Loss of appetite Insomnia Elevated blood sugar Decreased respirations Psychological Heightened response to color, sounds Distorted vision Sense of slowed time Magnified feelings Paranoia, panic Euphoria, peace Depersonalization Derealization Increased libido
64
Dynamics of Substance-Related Disorders
Cannabis Use Disorder A profile of the substance Marijuana Hashish Patterns of use
65
Cannabis Use Disorder Effects on the body
Cardiovascular (tachycardia, orthostatic hypotension) Respiratory (obstruction disorders) Reproductive (risk for infertility) Central nervous system (euphoria, depersonalization, disorientation) Sexual functioning
66
Cannabis-Induced Disorder
Intoxication Symptoms include impaired motor coordination, euphoria, anxiety, sensation of slowed time, impaired judgment Physical symptoms include conjunctival injection, increased appetite, dry mouth, and tachycardia Impairment of motor skills lasts for 8 to 12 hours
67
Cannabis-Induced Disorder (cont’d)
Withdrawal Occurs upon cessation of cannabis use that has been heavy and prolonged Symptoms occur within a week following cessation of use Symptoms include irritability, anger, aggression, anxiety, sleep disturbances, decreased appetite, depressed mood, stomach pain, tremors, sweating, fever, chills, or headache
68
Application of the Nursing Process
Nurses must begin relationship development with a substance abuser by examining own attitudes and personal experiences with substances.
69
Nursing Process: Assessment
Various assessment tools are available for determining the extent of the problem a client has with substances. Drug History and Assessment Clinical Institute Withdrawal Assessment of Alcohol Scale Michigan Alcoholism Screening Test (MAST) CAGE Questionnaire
70
Nursing Process: Assessment (cont’d)
CAGE Questionnaire Have you ever felt you should Cut down on your drinking? Have people Annoyed you by criticizing your drinking? Have you ever felt bad or Guilty about your drinking? Have you ever had a drink first thing in the morning to steady your nerves (Eye-opener)
71
Dual Diagnosis Clients with a coexisting substance disorder and mental disorder may be assigned to a special program that targets the dual diagnosis Program combines special therapies that target both problems
72
Nursing Diagnosis/Outcome Identification
Ineffective Denial related to weak, underdeveloped ego Outcome: Client will demonstrate acceptance of responsibility for own behavior and acknowledge association between personal problems and use of substance(s)
73
Nursing Diagnosis/Outcome Identification (cont’d)
* 07/16/96 Nursing Diagnosis/Outcome Identification (cont’d) Ineffective Coping related to inadequate coping skills and weak ego Outcome: Client will be able to demonstrate more adaptive coping mechanisms that can be used in stressful situations (instead of taking substances) *
74
Nursing Diagnosis/Outcome Identification (cont’d)
Imbalanced Nutrition less than body requirements/Fluid volume deficit related to drinking or taking drugs instead of eating Outcome: Client will be free from signs or symptoms of malnutrition/dehydration
75
Nursing Diagnosis/Outcome Identification (cont’d)
Risk for Infection related to malnutrition and altered immune condition Outcome: Shows no signs or symptoms of infection
76
Nursing Diagnosis/Outcome Identification (cont’d)
Chronic Low Self-Esteem related to weak ego, lack of positive feedback Outcome: Exhibits evidence of increased self-worth by attempting new projects without fear of failure and by demonstrating less defensive behavior toward others
77
Nursing Diagnosis/Outcome Identification (cont’d)
Deficient Knowledge (effects of substance abuse on the body) related to denial of problems with substances evidenced by abuse of substances Outcome: Verbalizes importance of abstaining from use of substances to maintain optimal wellness
78
Nursing Diagnosis/Outcome Identification (cont’d)
For the client withdrawing from CNS depressants Risk for Injury related to CNS agitation For the client withdrawing from CNS stimulants Risk for Suicide related to intense feelings of lassitude and depression, “crashing,” suicidal ideation
79
Planning/Implementation
Detoxification Provide safe and supportive environment Administer substitution therapy
80
Planning/Implementation (cont’d)
Intermediate care Provide explanations of physical symptoms Promote understanding and identify causes of substance dependency Help client accept use of substance as a problem Provide education and assistance to client and family
81
Planning/Implementation (cont’d)
Rehabilitation Encourage continued participation in long-term treatment Promote participation in outpatient support system Assist client to identify alternative sources of satisfaction Provide support for health promotion and maintenance Alcoholics Anonymous
82
Client/Family Education
Nature of the illness Effects of (substance) on the body Alcohol Other CNS depressants Hallucinogens Inhalants Opioids Cannabinols Ways in which use of substance affects life
83
Client/Family Education (cont’d)
Management of the illness Activities to substitute for (substance) in times of stress Relaxation techniques Progressive relaxation Tense and relax Deep breathing Autogenics
84
Client/Family Education (cont’d)
Management of the illness (cont’d) 3. Problem-solving skills 4. Essentials of good nutrition
85
Client/Family Education (cont’d)
Support services Financial assistance Legal assistance Alcoholics Anonymous (or other support group specific to another substance) One-to-one support person
86
Nursing Process: Evaluation
Evaluation involves reassessment to determine whether the nursing interventions have been effective in achieving the intended goals of care.
87
Treatment Modalities for Substance-Related Disorders (cont’d)
Psychopharmacology for substance intoxication and substance withdrawal (cont’d) Opioids Narcotic antagonists Naloxone (Narcan) Naltrexone (ReVia) Nalmefene (Revex) Methadone Buprenorphine Clonidine
88
Treatment Modalities for Substance-Related Disorders (cont’d)
Psychopharmacology for substance intoxication and substance withdrawal (cont’d) Depressants Phenobarbital (Luminal) Long-acting benzodiazepines
89
Treatment Modalities for Substance-Related Disorders (cont’d)
Psychopharmacology for substance intoxication and substance withdrawal (cont’d) Stimulants Minor tranquilizers Major tranquilizers Anticonvulsants Antidepressants
90
Treatment Modalities for Substance-Related Disorders (cont’d)
Psychopharmacology for substance intoxication and substance withdrawal (cont’d) Hallucinogens and cannabinols Benzodiazepines Antipsychotics
91
Treatment Modalities for Substance-Related Disorders (cont’d)
3. A client diagnosed with chronic alcoholism says to the nurse, “I’m tired of using and I want to stop. Is there a medication that can help me maintain sobriety?” About which medication would the nurse provide information? a) Carbamazepine (Tegretol) b) Clonidine (Catapres) c) Disulfiram (Antabuse) d) Folic acid (Folvite)
92
Treatment Modalities for Substance-Related Disorders (cont’d)
Correct answer: C Disulfiram is used as a deterrent to drinking. Ingestion of alcohol while disulfiram is in the body results in a syndrome of symptoms that can cause varying degrees of discomfort. It can even result in death if blood alcohol levels are high. It is important that the client understands that all alcohol, oral or topical, and medications that contain alcohol, are strictly prohibited when taking this drug.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.